<DOC>
	<DOCNO>NCT01518231</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy autologous peripheral hematopoietic stem cell transplantation ischemic stroke .</brief_summary>
	<brief_title>Autologous Hematopoietic Stem Cell Transplantation Ischemic Stroke</brief_title>
	<detailed_description>Stroke among main cause mortality disability elderly population still lack efficient therapy . Stem sell transplantation provide functional improvement cerebral ischemia rat model . Our study recruit 40 ischemic stroke patient divide 2 group ( 20 patient ) : treatment group control group . The former implanted peripheral blood stem cell anterior cerebral artery middle cerebral artery ( determined section infarction ) receive convention stroke therapy . The latter receive convention stroke therapy . The investigator expect transplantation peripheral hematopoietic stem cell safe efficient neurological recovery .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Antipyrine</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Phenylmethylpyrazolone</mesh_term>
	<criteria>age 40~70 consciousness disorder internal carotid artery territory infarction stroke happen &lt; 1 year stable hemiplegia , remain dependent daily life SSS ( Scandinavian Stroke Scale ) &lt; 40 pregnant woman ca n't tolerate test disease , heart failure , liver failure , renal failure , abnormal blood coagulation , AIDS , combine tumor special condition</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>stroke</keyword>
	<keyword>hematopoietic stem cell transplantation</keyword>
</DOC>